Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

FDA clarifies stricter stance on GLP-1 compounding: Reuters

Hims, historically seen as one of the largest sellers of copycat GLP-1s, sunk on the news.

J. Edward Moreno
Author: J. Edward Moreno

Written by

J. Edward Moreno

in

Business
←‘LOTR’ & ‘Dune’ VFX Firm Rodeo FX Heralds New Chapter As It Opens Bigger Paris Studio Integrating Mikros Animation
Globalstar surges after FT reports that Amazon is in talks to buy the satellite group→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube